IBDEI15S ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19708,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,19708,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,19708,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,19709,0)
 ;;=E11.9^^84^921^21
 ;;^UTILITY(U,$J,358.3,19709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19709,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,19709,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,19709,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,19710,0)
 ;;=E13.9^^84^921^22
 ;;^UTILITY(U,$J,358.3,19710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19710,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,19710,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,19710,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,19711,0)
 ;;=E16.2^^84^921^29
 ;;^UTILITY(U,$J,358.3,19711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19711,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,19711,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,19711,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,19712,0)
 ;;=E20.0^^84^921^34
 ;;^UTILITY(U,$J,358.3,19712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19712,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,19712,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,19712,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,19713,0)
 ;;=E20.9^^84^921^30
 ;;^UTILITY(U,$J,358.3,19713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19713,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,19713,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,19713,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,19714,0)
 ;;=E23.0^^84^921^31
 ;;^UTILITY(U,$J,358.3,19714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19714,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,19714,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,19714,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,19715,0)
 ;;=E27.1^^84^921^51
 ;;^UTILITY(U,$J,358.3,19715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19715,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,19715,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,19715,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,19716,0)
 ;;=E27.2^^84^921^1
 ;;^UTILITY(U,$J,358.3,19716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19716,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,19716,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,19716,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,19717,0)
 ;;=E27.3^^84^921^23
 ;;^UTILITY(U,$J,358.3,19717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19717,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,19717,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,19717,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,19718,0)
 ;;=E29.1^^84^921^52
 ;;^UTILITY(U,$J,358.3,19718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19718,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,19718,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,19718,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,19719,0)
 ;;=E55.9^^84^921^59
 ;;^UTILITY(U,$J,358.3,19719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19719,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,19719,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,19719,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,19720,0)
 ;;=E66.01^^84^921^38
 ;;^UTILITY(U,$J,358.3,19720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19720,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,19720,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,19720,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,19721,0)
 ;;=E66.8^^84^921^42
 ;;^UTILITY(U,$J,358.3,19721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19721,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,19721,1,4,0)
 ;;=4^E66.8
